Table 2. Parameters used in the study.
| Humoral parameters | Viruses used for the neutralization | |||||
| Protein Tot. | Region | Isotype | Viruses | Clade | Tropism | Target cells |
| CCR5 | ECL1tn:b | IgG-IgA | SOS 140 | Lab Strain B | R5 | U87 |
| HR2-gp41 | P1-HR2tn:c | IgG-IgA | SF162 | Lab Strain B | R5 | TZMbl |
| HR2-gp41 | T20-HR2tn:d | IgG-IgA | QH0692 | Primary B | R5 | TZMbl |
| HR1-gp41 | HR1tn:e | IgG-IgA | PVO | Primary B | R5 | TZMbl |
| gp41 | Consensus B | IgG-IgA | AC10 | Primary B | R5 | TZMbl |
| gp120 | IIIB | IgG-IgA | ZM214 | Primary C | R5 | TZMbl |
| gp120 | Bal | IgG-IgA | ||||
| ADCC | IgG |
1
aa sequence: YAAAQWDFGNTMCQ.
2
aa sequence: QNQQEKNEQELLELDKWASLWNWFNITNWYIK.
3
aa sequence: YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF.
4
aa sequence: GIKQLQARILAVERYLKDQQLLG.